0001193125-13-405401.txt : 20140310 0001193125-13-405401.hdr.sgml : 20140310 20131021170134 ACCESSION NUMBER: 0001193125-13-405401 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20131021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 CORRESP 1 filename1.htm Correspondence
LOGO    Katherine R. Kelly
   Vice President & Assistant General Counsel
     
     
     
   345 Park Avenue    New York, NY 10154-0037
   Tel 212-546-4852    Fax 212-546-9966
   katherine.kelly@bms.com
   October 21, 2013

VIA EDGAR

Mr. Jim B. Rosenberg

Senior Assistant Chief Accountant

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 

  Re: Bristol-Myers Squibb Company

Form 10-K for the Fiscal Year Ended December 31, 2012

Filed February 15, 2013

File No. 001-01136

Dear Mr. Rosenberg:

We have received the follow-up comment letter from the staff of the Securities and Exchange Commission (the “Commission”) dated October 4, 2013 responding to Bristol-Myers Squibb Company’s response letter dated September 9, 2013, with respect to the above-referenced Form 10-K for the fiscal year ended December 31, 2012. We are submitting this letter to confirm our conversation with the staff of the Commission on October 16, 2013 regarding the timing of our response to your comments. We anticipate providing a response by November 4, 2013.

 

Sincerely,
/s/ Katherine R. Kelly
Katherine R. Kelly
Vice President & Assistant General Counsel

 

cc: Charles Bancroft, Bristol-Myers Squibb Company

Sandra Leung, Bristol-Myers Squibb Company

GRAPHIC 2 g615326logo1.jpg GRAPHIC begin 644 g615326logo1.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`(P$O`P$1``(1`0,1`?_$`'0```$%`0$!`0$````` M```````&!P@)"@4#!`$"`0$`````````````````````$```!P$``@$#`@4" M!04````!`@,$!08'"``)$1(3%!4*(2(R%A($AN">WE>O*_>XJVT=7/M,RN; MCZ[-?9.J6EZM'A7X11_KV.)R:YK(IE4I;W$@QCPDTTY$K9LW<+D*1ZV$X6!^ M`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`>`> M`>`>`>!7;V!M^=2%^I?)\J\=6AW98DNJ:]EM+C9:VZ5<\M@G;T]9S:!IT`@X M=O4M>N$"JC)J/A;PP5.%FTWSA`JZ!C!`KI`TYCE*KNJ:?37O/.F9]L.GZK7] M'LJ4!<\W?TW6MRNVR0%:E="JAY")K&D9!+6M(S^+DUF[*6B3V*.A74D26,J0 M$):>IJ-U/ZL%[=4.- MG@JS5_"(NVSZ:MI9N,<%"L*KE"0C^U6GG$]DWZ_9+><0)%[%;]MISZ32J\Q4 MYSGZ\P.=TJ^<\:1*U*LT@NGK\_" M6N`A+36I1E.5RRQ$;/P$U&KD=1TO"3+)&1BI1@Y3$4W#*08N4U4CE$0.0X"' M\!\#*Y[6\JH>P>]'UA8UT!IVD/\`E72L&ZDT7:,1G-IM=0P,PX+G-KN=?ML[ M6XF>K\5$-2OX]-S,/'"P).D(Q,JIBHD5*<.'ZY[-5LV]P_5+#U^Z,SDO3-3N M7(R>W&SH:9*7+DK,NI8U:.=.D?0=) MF"878*>R;@/H>(T/'8MI)5^ M#GSH$@INXE3.LC2(>9%TE^*ZF#L4'!5"B0Y@$!\"O'V#V"2_\HGHHL]&U:]J MT;5]:Z/C)JJ5?2YM3&;Y!07,]MME0M#JG14F:G6.535GCG:RIDUCG:F(4AA( M4@@%XMXJD#>Z;:J7:&B[^MVNOR]?GF+63EH5P\B)9BNRD&R$O`OHR:C%5FJQ MB@NTKHS(:_$:?.J5H+S2NCKP2KS\$PE:F]WNK/4(=R MY54:/H&I(+'(9HY-]\-8]<]@?#=PR.[[[5.M^>;)B&:24;#Z%K<)K%,D\[I4 MK,+,F\7'V:WM)96#AG;Y>1;E3(NL03&6('_,'@<;0_9)P%DT7G$WI78_.5*B M->K3:ZYG(6#6*@P:W.DO%TFK6[PJJDG\+TMPY6*F67-],<)Q^G[WS\AX"UUK MM[CG!BQ9MGZCP/,1G*B]O\(E<]6I<&XF*1'L$I1Q;8IJ]F$W,C7C,G"9TG:) M#HN!53*D8YU"%,#<63V>^NNGR5'B+1VUS)`R.DTRL:'16LEL5);'LM(NR**] M,LT>8\N"8Q5O2<)C%J'$GZ@)P!`%!'X\!UNRU-R1Y&Z>5YC3%7HM/`MGRB2JL45V@8&*IR',F7ZO` MXFJ;/F=[J?2F-9CU7EN8;?0LHFPLEL:66CVB=YHE+M#V6$HFF7VHR4PDRBT8 M2?C%7J+68,U1=BP,0X@01'P,^'1EUT;&+M^WBLMG]B-MZ%J]CV2T0FZ;S7]" MCJ#SWT#5:CE]PNA-0MM>K$R>E2K&$:O5&X2CQ^Y068-`7JOV!ZGQCUNPGY+'^=MHLB&F2L5)R[FR3%C.SD"R#U-05I`$51<+%`HB?P%5[H_8"^]:'KPW M#IZL,HZ3T]FA"Y[C,;+D27BUM4T&0+!UV3DF2JB02D=46IG4XY9@("\;QAT? MDH'$Y0BCCOI9J>M25S/Z@I-JQ[2)6KBK5^U0`7B1S&`J86/QFR8QZ_.<.>\^[1Z]R2!L5 M9SVH9:&LZ_<*_ECO9;'0JO&PTI:6D3;K7(/GD[,(,2OY)-%V]%)=<1RB(WC_/F,AB5@(R/`Z\;3:67-)H)%<&L>2*NYIH*W(+/G8_9132< MG.HM_ME`3_R^`V+/V!\)R"VL(,>RN7G2N$(%=;0"&[9DH7+6YI(L+]^]G+9? MMUE()LY6(F=BF!7IRMQ^%C%((+&![`Y/L^,'Z-KW2V#R^`(JNT%]J9:S15^_VP M*7]R)9#J5+T!U7RN/I_'5FF=9F9)W%MW(G`$E%R$34'Y`HB(#\!SZ7VWQOH^ MNR>`Y]U7SO>-PA_S0D\DJ6R9]8=#9J1A3'E$%:E$S[N;_)BRD,+I($14;`4W MW2E^!^`^?2NYN+<:_N<-9ZTYOS8]+G(*L6]*[;5G5;7K%ELR#UU7Z[.H2MB: MK1<],,XUPN@S6*1PHW0.J!/ME$P`N6W3?-KVY06KCZ"K"4^>;EV=@@G*;UDJW04([:*%62$R9@,(*"I;=B]^L%OJ M=%UW,+K:<^550OM:J5^JECL%(6;NG+%=&WPT/+/)&M*HO6:R)RO4T1*JD<@_ M!BF``IY[@XPMER[?JVS,+"T=539LMBBYRYL-M7AFNZV+$] M'G!6S^Q9U659RZ8M* M6SJB#Y8>(N-7JRTU$7"C5W&4<-G8;0(_.Y:M2Z]CEY5\G7D(^O2#F/1G6Y"* M>`UUJYEUK>^F\9D-_KE6I,I7L>D.;L7SYC"9W1+9=,RH]H17S>4M>V-\8MRF M6Z[)1ZKV/N55:,E*1%VJ4K<>W01_5B/&P.%J7K\QRVYS>F>.U;HRGSC2P/,. ME'G2#[#$6CO:;""-?AD>RA&KIF4- M+',>*,^;^=\3P1C*(S:&0YC3<_&:;05?J[67;5N'K7+W2E3T)&^3L-$ M0$0XUK/M6AZ-`VEQ8%$(9`M_82^OW83>SN/R!2#>\L$LZE4U-OGXZ:U@`6R-OI2DFQK1')EP(Y,BD M8BHB<'Y1!P_2E1L/3_;)K7%Q5+6YVE[$U-S,%>O[ML2:K"SS3I% M5X@HZ:0<0`MW:I?J1:L_Y/H30^`A1S-D]6V'@/TVZ7R[W1FW*GM'Y*Y"U_2. M>H767D$MC6P9C/Z!9ZKKF?W%:RMG,$UG6=L_L_9>,P< M>D]A4CH2R?ME^K;GF66\DP4YT=[(9&^1$5(Q-3Q9A:T*C8F=[O\`3IF:=-XN M-I>EZ"=Y,M04EW1N=L]Y/]M+#N.WY=&[9']H]7V?N M$VGS%9:S]JSVU0D2]IMD??W`Y(_G2S>H=%UW_IQIE==O\`ABW(Y^R!!%,0"@SD+UWR/LH]#_K0E><] MSCL+ZLY?UK2;KC_059E53S&?Q\]T=J,!LM4/*5LK^38K3N=2@2*#0I2?DRL9 M')K'1:JK*@#C=34S%N:O?Y^W^PB@/ZE3*!B7-70>7P4"O.1#$T%&I9%=Z[3V M,L#EVDJ27M2A"`B9?X7E7JQA)]U50?D.*UR>U<\]J=@>BNLY].*R36J3V M)DLM"@*%6S3E6].E5_8CGK^123*C6F3QUG9JK68]$H@W):D#B8AU40."$P:E MZ-;NZ?>ERW;-/YSYPT;:]OCX&^:-T%'QLOHD)ZTUK2!(]P\DGI:[4P,V5=1TFX,DV3!1P7/_KT-[4?0_FN`HYIO7-]1XW[0JF=W M"[*0>DK:'_BTCRKUB;EIV?CR$O:479$IH]?6*@>(2`3+0J:;0J!B@W?L6K5- MX?UGOKV#<6:%S%O_`#RYD\BYQ]JGK`VV"A(!NWC:#7JIEV>M<=*YCV4S7GC> M"GTG$(S003BU/R57$>:232(Q:AJRW;KK-N8.0)GL/3:MH\?E=&H%*O\`;ZY" MUD)C0ZC4[(ZK;)\XDZPK(M53K41E/_ES21%U%T&K%R9,JRA"IG#+;[\7'#-A MSGG;VB^O3;\N_P#)0GM^,1O-]GYHT*LR5ZZ?0LUEC:_*4.VTNK/7B1D)( M&!T=TT!VBBF,2^,9!Q^((2)]:[:`G>[OW"\?V*QI*G1T[I]-@P@=%7BWRJG+ M4YGEL:9-7*8%G*BK(9JYC'[5J86J96[LYF?Y`"J=$/`J]XE2I%1YH_:5:W;$ MZG6$H[HOL"CRVF6$D-#?@M)RQ[+_`&M49"X2(-S-FDO855/P6*C@$UGIQ%,@ MJF_B$U*L_P``T/V1_ND$*H;)[;G[_A[)PL:$4WJDG3I:ZU_GFW&OSN11134A M9>F;/74 MW18!YELI2/SI&+>/?N$B75N=>7.T.8S**=895L8D$]UR3S1W^F,&BJBDH83* M-DR_<$R?@*KJ*5IM[]2W[>"D<_3]"E^OI_:O7%*X*C37T,_T5I(47+V;39[& MT4@EAFV5;IK1D5&X.%3$:MA1(D^$%2IE`+6OW*W&FC]K^J'9*;D,0_L^DY!9 MJCT-6J?%HK.I6X-\U++H6Z!B&3=-9U)39J)8I1RP9HD.N]>MDFZ1145*`A)7 MBOVR<,=`\0YSTVITCC>?5Z#S6OCL$-?]'J%5G\?N,'`,D;=4;S$2TLU?1$C% MR:2A6WUI@61;F17:_=272,8*TN%]6ROHCWR=J[)I@&D1TGB;DB[>MYQJ]7L- M1DI+ENCYG<>6 M?W$(T.NUY]Q2E[.>(6O.LDS909\\A=KFMASRH=D2F(2R2:C>C-(M'SJ&4 M20_37)$R#]DRA?`NMZ&Y@YKB/W#'JBI-M893H=:S4KD'V$WWJVJXI"0IIBW\K9WA\G9<\A[;"U_P#& M:2,9*:,R?M*X$@!6JLL8I$S_`%D3`H0/E=2-LMM_;I=,3A>1&D=&N69HV)2MUN: M$?2RZ:2:KYXB4ZYS')\^!$C+:NZYJ]5?HL]R=#KRDK/<,Q<91^JW,+&I35DL MG#VQW*R9YIA#-/I4=3DCE+A^V>0R/UD"-*Z1=8WQETS[$; MGDDC_EOI1KKO==RSV'@VJ&C/Z%"T-53G7''"+9DB[7M\%SO1*U%KM#D$2V-P M^-](J+*&.%DFPYFQUW/)ZCNI1_7WSS].EJQ:X@WT3-,NU:DV=BI-SAQ$Q4SR M-5M,6T?)I*?4W<_9%%9Z(WR(QOK?/T,MT"KZ=U7MD3BMNL- M.@*#H$7;.G;Y.)WY_L5Y_2ZC4LFU*\MVB+-5X5S-NZC5E2M8M=.S+HE"2_5V MR5E#![O:M!U/GC1VU8LMGW")N_*FO%>W7-IIZ5%Q9!4"E3>:T3#\?I6=65%=O8Z#4LTI=%9P4JBX;G$ARK MH*%.01*("`_'@>\3@>%P-.G\[@L6R:%S^UN`=VFBQ.-KUAY5YNGH"'-('B(.:PW,92 M'BC2SAN\E31L8^JZ[)B:3=M$E7`I$**RB9#'^3%`0!66_G3GS0:I5:)?<)QJ M[T>B&;'I%-M^84FRU2FG9-RLV9ZK79F#>Q%>,T:$!)(6B*(II@!2_`!\>!PK M]R7RMJUFBKIJ'-&`:/<8-%BVAK7?,Q@;#;,[J%BG(1E$NU)"+9 MQ$M,0[Q_&M8U^J9=NFBH0B*QA.0`,(CX"_L%>@+;"2E9M4'#V:MSC)>-FZ_8 M(QE,PDQ'.B"FYCY2*D4'+"09.$Q$JB2R9TSE'X$!#P$_0LRS;*XES`Y?GU'S M>">R"DL\A:%4X&GQ+N56;MFJTFYCJ\PCF:\@JU9HIF6,05#)I$*(_!2@`)2Q M\[<_7"VFO]MPO'+3>SN8MX>ZV/,:3-VTSN#*W)"NC6.3A'4P9S#D9I`U.*WU M-P2("8E^DOP$/\-Y\VR>[]Z<[)Z)A*[!QL+3:_RUQ75X:Q(61Q!8$RE"7W6- M-L2C5-%K&7'>-*)&F59BF#F-AZRP;'.N3&L9+0M$E(%L*RCDS6'D+=`2[N.:'<*F4,DBYXMNGEEVD__D6RXOG$Y>33L>W:-(^:4MDG M6W,ZK+1[5@@F@X,N*R)$4P(8H$+\`]UHJU8O%+>P=DJUHB( M^?KEAA9)`[61B)N$E6[N-E8M^V4,FLW724253,)3%$!$/`82F<5\<9Q?2:IG MG)W-5$TY,PG2T6FX7F%8O*1Q(9,RB-KA:NRG45#IG$IC%7`3%'X$1#P$WT]S M5C>BQLEL+WDO'.A>AZ'5Y%#(Y*W5#,4[ZUF#I+%B6$!IU[B'1Z@@S?.ORB+? M>^AL<@JI$,L!0$(!>I7U^SF7>K'".'/83S9CMMG,0E;VQ(;R40_CXQXDUNRC$R3AN5X@NU5,4YDE2&,%E3'CCD.+;NVD;RMSA' MM7]2+0'[9CAV8M&[VB$7;.B4IVBA6$TW-2(Z9HJ!&G`S,%$B&^W\E*(!S;%P M_P`76VD1V:6CD;F6?SR'-)GAJ-+83E[ZI0RLRX!W+K0]?<5<\7$KR;L`5<*- MTDSJJ@!S")@^?`6%0YAYLS[-Y/'*+S]BE.R2;4!:;S&LY;2(2@3C@/QOEU-U M".@V\!,.SBR1$RKENJH\.Y6YVQZ[2*;I!W;M"S59KL9(HLWH!_O(D4*DJ/\3%$?X^!)GP(=3?KPX&LNE_Y MFL7$_)\[K0O@E#Z1,<]Y1)7565!51<>C64+'[[@^0[.TK2BZM;3T[/*I=35X[HA$G9H%:P1;]>&_,13*1 M;\8R0*D`"G^HO\/`Y,_R%RA:LRKF*V7F7`)_':>]"2J>4S&/9](YQ6)$".2` M_K](=5Y6M0[WZ'JP?=;MDS_[I_X_S#\A_7_:-RK_`'W3=1_[;,('2\YBJ_`Y M_H(Y/11NM'@ZHP&+K$-4;0,$,W7(JO1HB@R;LUT4FR(_0F4I?X>!4M[7_6:; M2.2G&/>OKDW$:IHE]Z(P/5M&?TAEEN$,):(Q31&NA+.;=+MHZ+=6B9D#@Y;L M/J2O^#>.I&'XAY+C)![ M:4+PX?,>>,F;/!N+9TH];69)RE4RK-YML]5.LFX3,14BIS'*(&,81!9-.+>/ MV#K1WS#EGGED]V*.?Q&MO&F-Y\V=:A%2DJA.24;H2Z-?(K\;O#19:N=R@B!6<<[=*J&(I]A0@6I?IS#]/_`$G\)K^E_A?I MWZ=]A/\`"_`^Q^-^%^-]/V?Q?Q_Y/M_'T_1_#X^/`^SP/%?^@/\`H_U!_P!? M^C_0?]/_`'?\/`_$OZ/_`,_]?_U?T?\`)_\`/_T\#W\`\`\`\`\`\`\`\`\` I\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\`\#_]D_ ` end